Abstract:The aqueous decoctions of Vernonia amygdalina (VA) leaves and roots are widely used in traditional African medicine as an antidiabetic remedy. The amount of luteolin and vernodalol in leaf and root extracts was detected, and their role was studied regarding α-glucosidase activity, bovine serum albumin glycation (BSA), reactive oxygen species (ROS) formation, and cell viability, together with in silico absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Vernodalol did not affect α-glucosidase activity, whereas luteolin did. Furthermore, luteolin inhibited the formation of advanced glycation end products (AGEs) in a concentration-dependent manner, whereas vernodalol did not reduce it. Additionally, luteolin exhibited high antiradical activity, while vernodalol demonstrated a lower scavenger effect, although similar to that of ascorbic acid. Both luteolin and vernodalol inhibited HT-29 cell viability, showing a half-maximum inhibitory concentration (IC50) of 22.2 μM (−Log IC50 = 4.65 ± 0.05) and 5.7 μM (−Log IC50 = 5.24 ± 0.16), respectively. Finally, an in silico ADMET study showed that both compounds are suitable candidates as drugs, with appropriate pharmacokinetics. This research underlines for the first time the greater presence of vernodalol in VA roots compared to leaves, while luteolin is prevalent in the latter, suggesting that the former could be used as a natural source of vernodalol. Consequently, root extracts could be proposed for vernodalol-dependent antiproliferative activity, while leaf extracts could be suggested for luteolin-dependent effects, such as antioxidant and antidiabetic effects.

Stigmastane-type steroid saponins from the leaves of Vernonia amygdalina and their α-glucosidase and xanthine oxidase inhibitory activities

Stigmastane-type steroid saponins from the leaves of Vernonia amygdalina Del

Alpha-Glucosidase Inhibitory Activity of Saponins Isolated from Vernonia gratiosa Hance

Steroidal Saponins from Vernonia Amygdalina Del. and Their Biological Activity

Polyhydric Stigmastane-Type Steroids Derivative from Vernonia Amygdalina and Their Anti-Neuroinflammatory Activity

Stigmastane-type Steroids with Unique Conjugated Δ7,9(11) Diene and Highly Oxygenated Side Chains from the Twigs of Vernonia Amygdalina.

Highly oxygenated antiplasmodial and non-hemolytic Δ 7,9(11) stigmastane-type steroids from the twigs of Vernonia amygdalina Delile

New Triterpenoid Saponins with Strong Alpha-Glucosidase Inhibitory Activity from the Roots of Gypsophila Oldhamiana.

Luteolin and Vernodalol as Bioactive Compounds of Leaf and Root Vernonia amygdalina Extracts: Effects on α-Glucosidase, Glycation, ROS, Cell Viability, and In Silico ADMET Parameters

Two new rotenoid glycosides from the rhizomes of Stemona curtisii Hook. f

New Steroids from Anemarrhena Asphodeloides Rhizome and Their Α-Glucosidase Inhibitory Activity.

Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina.

New α-glucosidase inhibitory xanthones from the fruits of Garcinia schomburgkiana

Bisabolane-type Sesquiterpenes from Vernonia Amygdalina: Absolute Configuration and Anti-Inflammatory Activity

New prenyl flavanone and diarylbutanol from Uvaria siamensis stem bark and their α-glucosidase inhibitory activity

Cycloartane-type triterpenoids from the leaves of Sandoricum koetjape and their efficacy on α-glucosidase inhibition activity

Components with Anti-Diabetic Activity Isolated from the Leaves and Twigs of Glycosmis pentaphylla Collected in Vietnam

Phenolic glycosides from Viburnum chinshanense leaves and their α‐amylase and α‐glucosidase inhibitory activity

Xanthone Sulfonamide Derivatives-A Novel Series of Α-Glucosidase Inhibitors with Different Inhibitory Types

β-amyrin heptadecanoate, a new oleanane triterpenoid with α-glucosidase inhibitory and cytotoxic activities from the leaves of Averrhoa bilimbi L.

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum